The Stage is Set
LOS ANGELES, Oct. 7, 2024 — A legal battle is brewing as The Schall Law Firm initiates a class action lawsuit against Metagenomi, Inc. (“Metagenomi” or “the Company”) with MGX at its core, citing violations of federal securities laws.
The Call to Arms
Investors who partook in the Company’s IPO on February 9, 2024 might have a stake in this lawsuit and are urged to reach out to the firm before November 25, 2024.
Unveiling the Deception
The crux of the matter is centered around alleged false and misleading statements made by the Company concerning its ties with Moderna during the IPO period. While trumpeting a Strategic Collaboration and License Agreement inked on October 29, 2021, the Company abruptly disclosed post-IPO that its collaboration with Moderna had come to an unceremonious end. This revelation rocked the market and led to investor losses.
A Road to Redemption
To seek reparation for losses incurred, affected shareholders are encouraged to stand up and be counted in this legal tussle.
The Schall Law Firm, known worldwide for its prowess in securities class action lawsuits and shareholder rights litigation, is at the helm of this crusade, beckoning investors to join forces in pursuit of justice.
This press release serves as a clarion call for aggrieved investors to step forward and assert their rights.
View original content to download multimedia:Read more
SOURCE The Schall Law Firm
